Latest filing published 17 Jul 2026 for Catalyst Pharmaceuticals, INC., €13k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Gregg Russo: trading record in brief
All filings by Gregg Russo on record concern Catalyst Pharmaceuticals, Inc. Over a trading history stretching from 17 February 2026 to 15 July 2026, the count stands at 3 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 17 July 2026 came the latest disclosure, a transaction for €13k in Catalyst Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Gregg Russo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 476 shares@ US$31.50Common Stock, par value $0.001 per shareSEC:0001161697-26-000181:0
- 687 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-26-000044:0
2 of 2 declarations
